Rad AI Strengthens Leadership with Chief Operating and First Chief Clinical Officers

Rad AI Strengthens Leadership Team

Rad AI, a prominent player in AI-powered radiology workflow solutions, has taken significant steps to enhance its operational and clinical strategies with the announcement of key appointments in its leadership team. On April 29, 2026, the company introduced David Leonard as its new Chief Operating Officer (COO) and Dr. Elizabeth Bergey as its first Chief Clinical Officer (CCO). These strategic moves represent Rad AI's commitment to operational excellence and physician-led clinical innovation, aimed at managing growing workloads in the radiology sector.

Focused Leadership for Growth

As the demand for radiology services continues to rise, healthcare systems face increasing pressure to maintain efficiency and quality across complex workflows. Recognizing these challenges, Rad AI's CEO, Doktor Gurson, emphasized the necessity of combining deep clinical leadership with operational discipline. He stated, “That focus requires both deep clinical leadership and the operational discipline to deliver at scale.” With the addition of Leonard and Dr. Bergey, Rad AI is poised to tackle the intricacies of modern radiology.

David Leonard's Role as COO

David Leonard, who previously served as Rad AI’s Head of Operations, Strategy, and Investor Relations, now assumes the role of COO. Leonard brings a wealth of experience from high-growth technology sectors, where he has held various senior leadership roles focused on enhancing operational efficiency and developing cross-functional teams. His primary objective as COO will be to scale Rad AI's internal infrastructure, ensuring effective deployment of their innovative products in the market. Leonard aims to translate new partnerships into sustainable success for Rad AI, facilitating deeper integrations within the healthcare ecosystem.

Dr. Elizabeth Bergey's Transition to CCO

Dr. Elizabeth Bergey, a distinguished board-certified radiologist and an accomplished healthcare executive, steps into the role of CCO after her tenure as Chief Medical Innovation Officer. With a strong background as the former President and CEO of Quantum Radiology, one of the Southeast’s largest radiology groups, Dr. Bergey possesses a deep understanding of the financial and administrative pressures faced by radiology practices today. In her new position, she will lead Rad AI's clinical strategy and oversee medical affairs, acting as an essential link between clinical innovations and real-world applications.

Commitment to Radiology Innovation

The appointments of Leonard and Dr. Bergey come at a crucial time when radiology departments are grappling with staffing shortages and the need for improved patient follow-up care. Rad AI's product suite, including Rad AI Reporting, Rad AI Impressions, and Rad AI Continuity, aims to address these pressing challenges within the field.

In 2025, KLAS recognized Rad AI as one of the top five AI partners for health systems, a testament to its dedication to innovation and quality. Furthermore, the company was listed among the fastest-growing firms in the 2025 Inc. 5000 and Deloitte Fast 500 rankings.

Looking Ahead

With both Leonard and Dr. Bergey joining the executive leadership team, Rad AI is better equipped to meet the rising demands of radiologists and to ensure that the company remains a reliable ally for healthcare providers facing increasing case loads. As they chart a course for future innovations, Rad AI’s commitment to using AI to transform radiology practices and enhance patient care remains paramount.

To learn more about Rad AI and its game-changing solutions in radiology, visit www.radai.com or follow them on LinkedIn.